FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081500 [Registered on: 03/03/2025] Trial Registered Prospectively
Last Modified On: 25/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment of Primary Insomnia disease symptoms such as difficulty initiating or maintaining sleep, sleep interruption, reduction in sleep time, day time fatigue etc, using Ayurvedic formulations  
Scientific Title of Study   A single blind randomized controlled clinical study to evaluate the combined efficacy of Ksheerabala taila pichu with Mamsyadi kwatha and Sahadevi taila pichu with Simhimuladi kwatha in Anidra with special reference to Primary Insomnia  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashwini Deshmukh 
Designation  PG Scholar 
Affiliation  Shri DGM ayurvedic medical college, kalsapur road, shivanand nagar Gadag. 582103 
Address  Ashwini Deshmukh Dept of Kayachikitsa opd number 03 shri dgm ayurvedic medical college, Kalsapur road, shivanand nagar Gadag. 582103

Gadag
KARNATAKA
582103
India 
Phone  8861823715  
Fax    
Email  ashwinid903@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santosh N Belavadi 
Designation  Principal and Professor  
Affiliation  Shri DGM ayurvedic medical college, kalsapur road, shivanand nagar Gadag. 582103 
Address  Dr Santosh N Belavadi Dept of Kayachikitsa opd number 03 shri dgm ayurvedic medical college, Kalsapur road, shivanand nagar Gadag. 582103

Gadag
KARNATAKA
582103
India 
Phone  9886916367  
Fax    
Email  hardikasnb@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwini Deshmukh  
Designation  PG Scholar 
Affiliation  Shri DGM ayurvedic medical college, kalsapur road, shivanand nagar Gadag. 582103 
Address  Ashwini Deshmukh Dept of Kayachikitsa opd number 03 shri dgm ayurvedic medical college, Kalsapur road, shivanand nagar Gadag. 582103

Gadag
KARNATAKA
581203
India 
Phone  8861823715  
Fax    
Email  ashwinid903@gmail.com  
 
Source of Monetary or Material Support  
Shri DGM Ayurvedic Medical College And Hospital Gadag. 582103 
 
Primary Sponsor  
Name  Dr Ashwini Deshmukh 
Address  Shri DGM Ayurvedic Medical College And Hospital PG PhD Centre Kalsapur road,Shivanand nagar Gadag. 582103 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashwini Deshmukh  Shri DGM Ayurvedic Medical College PG Phd Centre and Hospital Gadag 582103  Dept of KayaChikitsa OPD No 03 Gadag Karnataka
Gadag
KARNATAKA 
8861823715

ashwinid903@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DGM Ayurvedic medical college ethical clearnce committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G470||Insomnia. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-mUrdhatailam/ Sirastailam, मूर्धतैलम्/ शिरस्तैलम् (Procedure Reference: Sushruta Samhita, Procedure details: A square piece of cotton cloth of the size 12 angula is soaked in sneha and placed over the head such as it does not leak. )
(1) Medicine Name: Sahadevi Taila, Reference: Shodala nighantu , Route: Topical, Dosage Form: Taila, Dose: 100(ml), Frequency: od, Duration: 10 Days
2Comparator ArmProcedure-mUrdhatailam/ Sirastailam, मूर्धतैलम्/ शिरस्तैलम् (Procedure Reference: Sushruta Samhita , Procedure details: A square piece of cotton cloth of the size 12 angula is soaked in sneha and placed over the head such as it does not leak.)
(1) Medicine Name: Ksheerabala Taila , Reference: Sahasrayoga Tailaprakarana , Route: Topical, Dosage Form: Taila, Dose: 100(ml), Frequency: od, Duration: 10 Days
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Subjects presents with symptoms like Jrumbha, Tandra, Angamarda, Klama, Shiroshula
and sign and symptoms of Primary Insomnia like difficulty initiating/maintaining sleep,
sleep interruption, reduction in sleep time, daytime fatigue since 1 month.
2.Subjects of age group 30-60 years.
3.Subjects of both genders.
4.Subjects fit for Pichukarma.
5.Subjects who willing to participate and gives written consent. 
 
ExclusionCriteria 
Details  •Subjects with cancer, heart disease, asthma, gastroesophageal reflux disease, thyroid disease, parkinsons disease, alzheimers disease, sleep apnea and restless leg syndrome.
•Subjects with psychiatric illness like schizophrenia, major depressive disorder, psychosis, epilepsy and anxiety disorders.
•Subjects with chronic liver and kidney disorders.
•Subjects with diabetes and hypertension.
•Pregnant women and lactating women.
•Subject with alcohol dependency and drug dependence.
•Those who are working in night shifts.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction of sign and symptoms like Jrumbha, Tandra,
Angamarda, Klama, Shiroshula of Anidra with special reference to Primary Insomnia. 
30 days  
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in the scores of Athens Insomnia Scale (AIS)  45 days  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   12/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Sleep has a restorative function and is important for conservation of energy and growth. In Ayurveda, Nidra is considered as an important component of Trayopastambha i.e Ahara, Nidra, and Bramhacharya. This aphorism of Acharya Charaka shows the necessity of Nidra. Acharya Charaka stated that happiness and misery, stoutness and thinness, strength and debility, virility and impotence, knowledge and ignorance as well as life and death all are depends on sleep.
Persistent insomnia can leads to impairment of day time functioning, injury due to accidents and the development of major depression. Insomnia is associated with substantial impairment in an individuals quality of life. Various risk factors associated with increased prevalence of chronic insomnia including older age, female gender and comorbid medical and psychiatric conditions.
Increasing age predisposes to sleep disorders (5% incidence in persons aged 30-50 years and 30% in those aged 50 years or older). people who are elderly experience a decrease in total sleep time, with more frequent awakenings during night. Elderly persons also have higher incidence. Hormonal variations during menstrual cycle or during menopause may cause disruption in sleep.
The surveys provide estimates of the prevalence of Insomnia based on insomnia criteria as defined by the DSM (Diagnostic and Statistical Manual of Insomnia)-4 recognises that about 1/3rd of general population presents at least one of them. When daytime consequences of insomnia are taken into account, the prevalence is between 99% - 15%, 8 18% of general population are having sleep dissatisfactions.
 
Close